Ligation of MHC class II molecules differentially upregulates TNFβ gene expression in B cell lines of different MHC class II haplotypes

Human Immunology

Volumn 60, Issue 4, 1999, Pages 312-322

  Guo, Wenyan ^a   Mourad, Walid ^a   Charron, Dominique ^b   Al Daccak, Reem ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b INSERM   (France)

Author keywords

B cells; Haplotype; MHC class II; Superantigens; TNF

Indexed keywords

CYTOKINE; HLA DR ANTIGEN; LYMPHOTOXIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY; PHORBOL 13 ACETATE 12 MYRISTATE; STAPHYLOCOCCUS ENTEROTOXIN A;

ARTICLE; B LYMPHOCYTE; BINDING AFFINITY; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE EXPRESSION REGULATION; HAPLOTYPE; LIGATION; LYMPHOBLASTOID CELL LINE; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; ANTIGENS, SURFACE; B-LYMPHOCYTES; BINDING, COMPETITIVE; CELL LINE, TRANSFORMED; ENTEROTOXINS; GENE EXPRESSION REGULATION; HAPLOTYPES; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DP ANTIGENS; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; LIGANDS; LYMPHOTOXIN-ALPHA; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS; UP-REGULATION;

EID: 0032913783     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(98)00131-1     Document Type: Article

References (55)

1. Chatila T., Geha R.S. Signal transduction by microbial superantigens via MHC class II molecules. Immunol Rev. 131:1993;43-59.
2. Scherer M.T., Ignatowicz L., Winslow G.M., Kappler J.W., Marrack P. Superantigens bacterial and viral proteins that manipulate the immune system . Annu Rev Cell Biol. 9:1993;101-128.
3. Aoudjit F., Al-Daccak R., Léveillé C., Mourad W. Effects and mechanisms underlying the interaction of bacterial superantigens with MHC class II-positive cells. Thibodeau J., Sékaly R. Bacterial superantigens: Stucture, function and therapeutic potential. 1995;147-160 R. G. Landes Company, Austin.
4. Al-Daccak R., Damaj B., Naccache P.H., Mourad W. Superantigens initiate cognate CD4+ T cell/B cell interactions leading to early activation and proliferation of B cells. Eur J Immunol. 25:(9):1995;2539-2543.
5. Mooney N.A., Grillot Courvalin C., Hivroz C., Ju L.Y., Charron D. Early biochemical events after MHC class II-mediated signaling on human B lymphocytes. J Immunol. 145:(7):1990;2070-2076.
6. Truman J.P., Ericson M.L., Choqueux Seebold C.J., Charron D.J., Mooney N.A. Lymphocyte programmed cell death is mediated via HLA class II DR. Int Immunol. 6:(6):1994;887-896.
7. Mourad W., Geha R.S., Chatila T. Engagement of major histocompatibility complex class II molecules induces sustained, lymphocyte function-associated molecule 1-dependent cell adhesion. J Exp Med. 172:(5):1990;1513-1516.
8. Al-Daccak R., Mehindate K., Hebert J., Rink L., Mecheri S., Mourad W. Mycoplasma arthritidis-derived superantigen induces proinflammatory monokine gene expression in the THP-1 human monocytic cell line. Infect Immun. 62:(6):1994;2409-2416.
9. Mehindate K., Al-Daccak R., Schall T.J., Mourad W. Induction of chemokine gene expression by major histocompatibility complex class II ligands in human fibroblast-like synoviocytes Differential regulation by interleukin-4 and dexamethasone . J Biol Chem. 269:(51):1994;32063-32069.
10. Mehindate K., Al-Daccak R., Dayer J.M., Kennedy B.P., Kris C., Borgeat P., Poubelle P.E., Mourad W. Superantigen-induced collagenase gene expression in human IFN-gamma-treated fibroblast-like synoviocytes involves prostaglandin E2 Evidence for a role of cyclooxygenase-2 and cytosolic phospholipase A2 . J Immunol. 155:(7):1995;3570-3577.
11. Mehindate K., Al-Daccak R., Damdoumi F., Mourad W. Synergistic effect between CD40 and class II signals overcome the requirement for class II dimerization in superantigen-induced cytokine gene expression. Eur J Immunol. 26:(9):1996;2075-2080.
12. Mehindate K., Thibodeau J., Dohlsten M., Kalland T., Sekaly R.P., Mourad W. Cross-linking of major histocompatibility complex class II molecules by staphylococcal enterotoxin A superantigen is a requirement for inflammatory cytokine gene expression. J Exp Med. 182:(5):1995;1573-1577.
13. Bernatchez C., Al-Daccak R., Mayer P.E., Mehindate K., Rink L., Mecheri S., Mourad W. Functional analysis of mycoplasma arthritidis-derived mitogen interactions with class II molecules. Infect Immun. 65:(6):1997;2000-2005.
14. Al-Daccak R., Mehindate K., Damdoumi F., Etongue-Mayer P., Nilsson H., Antonsson P., Sundstrom M., Dohlsten M., Sekaly R.P., Mourad W. Staphylococcal enterotoxin D is a promiscuous superantigen offering multiple modes of interactions with the MHC class II receptors. J Immunol. 160:(1):1998;225-232.
15. Altomonte M., Pucillo C., Damante G., Maio M. Cross-linking of HLA class II antigens modulates the release of tumor necrosis factor-alpha by the EBV-B lymphoblastoid cell line JY. J Immunol. 151:(10):1993;5115-5122.
16. Coral S., Pucillo C., Leonardi A., Fonsatti E., Altomonte M., Maio M. Triggering of HLA-DR antigens differentially modulates tumor necrosis factor alpha release by B cells at distinct stage of maturation. Cell Growth Differ. 8:(5):1997;581-588.
17. Corzo D., Salazar M., Granja C.B., Yunis E.J. Advances in HLA genetics. Exp Clin Immunogenet. 12:(3):1995;156-170.
18. Charron D. HLA class II disease associations molecular basis . J Autoimmun. 5:1992;45-53.
19. Alvarez-Ossorio L., Johannsen M., Alvarez-Ossorio R., Nicklas W., Kirchner H., Rink L. Cytokine induction by Mycoplasma arthritidis-derived superantigen (MAS), but not by TSST-1 or SEC-3, is correlated to certain HLA-DR types. Scand J Immunol. 47:(1):1998;43-47.
20. Alvarez-Ossorio L., Johannsen M., Russlies M., Kirchner H., Rink L. HLA-dependent heterogeneous T cell response to Mycoplasma arthritis-derived superantigen (MAS). Med Microbiol Immunol (Berl). 185:(4):1997;245-251.
21. Rink L., Nicklas W., Luhm J., Kruse R., Kirchner H. Induction of a proinflammatory cytokine network by Mycoplasma arthritis-derived superantigen (MAS). J Interferon Cytokine Res. 16:(10):1996;861-868.
22. Clark S.C., Kamen R. The human hematopoietic colony-stimulating factors. Science. 236:(4806):1987;1229-1237.
23. Estrov Z., Kurzrock R., Pocsik E., Pathak S., Kantarjian H.M., Zipf T.F., Harris D., Talpaz M., Aggarwal B.B. Lymphotoxin is an autocrine growth factor for Epstein-Barr virus-infected B cell lines. J Exp Med. 177:(3):1993;763-774.
24. De Togni P., Goellner J., Ruddle N.H., Streeter P.R., Fick A., Mariathasan S., Smith S.C., Carlson R., Shornick L.P., Strauss-Schoenberger J., et al. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin (see comments). Science. 264:(5159):1994;703-707.
25. Kehrl J.H., Alvarez-Mon M., Delsing G.A., Fauci A.S. Lymphotoxin is an important T cell-derived growth factor for human B cells. Science. 238:(4830):1987;1144-1146.
26. Ryffel B., Di Padova F., Schreier M.H., Le Hir M., Eugster H.P., Quesniaux V.F. Lack of type 2 T cell-independent B cell responses and defect in isotype switching in TNF-lymphotoxin alpha-deficient mice. J Immunol. 158:(5):1997;2126-2133.
27. Sung S.S., Jung L.K., Walters J.A., Jeffes E.Wd., Granger G.A., Fu S.M. Production of lymphotoxin by isolated human tonsillar B lymphocytes and B lymphocyte cell lines. J Clin Invest. 84:(1):1989;236-243.
28. Worm M., Geha R. CD40 ligation induces lymphotoxin alpha gene expression in human B cells. Int Immunol. 6:(12):1994;1883-1890.
29. Worm M., Geha R.S. CD40-mediated lymphotoxin alpha expression in human B cells is tyrosine kinase dependent. Eur J Immunol. 25:(9):1995;2438-2444.
30. Worm M.M., Tsytsykova A., Geha R.S. CD40 ligation and IL-4 use different mechanisms of transcriptional activation of the human lymphotoxin alpha promoter in B cells. Eur J Immunol. 28:(3):1998;901-906.
31. Fermand J.P., Schmitt C., Brouet J.C. Distribution of class IIDQ antigens on normal and leukemic lymphoid cells. Eur J Immunol. 15:(12):1985;1183-1197.
32. Gray P.W., Aggarwal B.B., Benton C.V., Bringman T.S., Henzel W.J., Jarrett J.A., Leung D.W., Moffat B., Ng P., Svedersky L.P., et al. Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activity. Nature. 312:(5996):1984;721-724.
33. Aoudjit F., Bosse M., Stratowa C., Voraberger G., Audette M. Regulation of intercellular adhesion molecule-1 expression by retinoic acid analysis of the 5′ regulatory region of the gene . Int J Cancer. 58:(4):1994;543-549.
34. Vincent R., Louis P., Gongora C., Papa I., Clot J., Eliaou J.F. Quantitative analysis of the expression of the HLA-DRB genes at the transcriptional level by competitive polymerase chain reaction. J Immunol. 156:(2):1996;603-610.
35. Heslop H.E., Rooney C.M. Adoptive cellular immunotherapy for EBV lymphoproliferative disease. Immunol Rev. 157:1997;217-222.
36. Grimaldi M.C., Clayton J., Pontarotti P., Cambon-Thomsen A., Crouau-Roy B. New highly polymorphic microsatellite marker in linkage disequilibrium with HLA-B. Hum Immunol. 51:(2):1996;89-94.
37. Jongeneel C.V., Briant L., Udalova I.A., Sevin A., Nedospasov S.A., Cambon-Thomsen A. Extensive genetic polymorphism in the human tumor necrosis factor region and relation to extended HLA haplotypes. Proc Natl Acad Sci USA. 88:(21):1991;9717-9721.
38. Nedospasov S.A., Udalova I.A., Kuprash D.V., Turetskaya R.L. DNA sequence polymorphism at the human tumor necrosis factor (TNF) locus Numerous TNF/lymphotoxin alleles tagged by two closely linked microsatellites in the upstream region of the lymphotoxin (TNF-beta) gene . J Immunol. 147:(3):1991;1053-1059.
39. Weissensteiner T., Lanchbury J.S. TNFB polymorphisms characterize three lineages of TNF region microsatellite haplotypes. Immunogenetics. 47:(1):1997;6-16.
40. Bouma G., Crusius J.B., Oudkerk Pool M., Kolkman J.J., von Blomberg B.M., Kostense P.J., Giphart M.J., Schreuder G.M., Meuwissen S.G., Pena A.S. Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles Relevance for inflammatory bowel disease . Scand J Immunol. 43:(4):1996;456-463.
41. Bouma G., Xia B., Crusius J.B., Bioque G., Koutroubakis I., Von Blomberg B.M., Meuwissen S.G., Pena A.S. Distribution of four polymorphisms in the tumour necrosis factor (TNF) genes in patients with inflammatory bowel disease (IBD). Clin Exp Immunol. 103:(3):1996;391-396.
42. Pociot F., Briant L., Jongeneel C.V., Molvig J., Worsaae H., Abbal M., Thomsen M., Nerup J., Cambon-Thomsen A. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells a possible link to insulin-dependent diabetes mellitus . Eur J Immunol. 23:(1):1993;224-231.
43. Frank K.H., Fussel M., Conrad K., Rihs H.P., Koch R., Gebhardt B., Mehlhorn J. Different distribution of HLA class II and tumor necrosis factor alleles (TNF-308 2, TNFa2 microsatellite) in anti-topoisomerase I responders among scleroderma patients with and without exposure to quartz/metal dust . Arthritis Rheum. 41:(7):1998;1306-1311.
44. Newton D.J., Bowen-Jones D., Crosby I., Barnes R.M., Flanagan B.F. TNFB gene polymorphism in insulin-dependent diabetes mellitus association with HLA-DR alleles . Eur J Immunogenet. 25:(1):1998;39-41.
45. Mycko M., Kowalski W., Kwinkowski M., Buenafe A.C., Szymanska B., Tronczynska E., Plucienniczak A., Selmaj K. Multiple sclerosis the frequency of allelic forms of tumor necrosis factor and lymphotoxin-alpha . J Neuroimmunol. 84:(2):1998;198-206.
46. Manz M.G., Melms A., Sommer N., Muller C.A. Myasthenia gravis and tumor necrosis factor beta polymorphisms linkage disequilibrium but no association beyond HLA-B8 (In Process Citation) . J Neuroimmunol. 90:(2):1998;187-191.
47. Fleury S., Thibodeau J., Croteau G., Labrecque N., Aronson H.E., Cantin C., Long E.O., Sekaly R.P. HLA-DR polymorphism affects the interaction with CD4. J Exp Med. 182:(3):1995;733-741.
48. Scholl P.R., Diez A., Karr R., Sekaly R.P., Trowsdale J., Geha R.S. Effect of isotypes and allelic polymorphism on the binding of staphylococcal exotoxins to MHC class II molecules. J Immunol. 144:(1):1990;226-230.
49. Lavoie P.M., Thibodeau J., Cloutier I., Busch R., Sekaly R.P. Selective binding of bacterial toxins to major histocompatibility complex class II-expressing cells is controlled by invariant chain and HLA-DM. Proc Natl Acad Sci USA. 94:(13):1997;6892-6897.
50. Wen R., Broussard D.R., Surman S., Hogg T.L., Blackman M.A., Woodland D.L. Carboxy-terminal residues of major histocompatibility complex class II-associated peptides control the presentation of the bacterial superantigen toxic shock syndrome toxin-1 to T cells. Eur J Immunol. 27:(3):1997;772-781.
51. Roucard C., Garban F., Mooney N.A., Charron D.J., Ericson M.L. Conformation of human leukocyte antigen class II molecules Evidence for superdimers and empty molecules on human antigen presenting cells . J Biol Chem. 271:(24):1996;13993-14000.
52. Tate K.M., Lee C., Edelman S., Carswell-Crumpton C., Liblau R., Jones P.P. Interactions among polymorphic and conserved residues in MHC class II proteins affect MHC-peptide conformation and T cell recognition. Int Immunol. 7:(5):1995;747-761.
53. Angelisova P., Hilgert I., Horejsi V. Association of four antigens of the tetraspans family (CD37, CD53, TAPA-1, and R2/C33) with MHC class II glycoproteins. Immunogenetics. 39:(4):1994;249-256.
54. Szollosi J., Horejsi V., Bene L., Angelisova P., Damjanovich S. Supramolecular complexes of MHC class I, MHC class II, CD20, and tetraspan molecules (CD53, CD81, and CD82) at the surface of a B cell line JY. J Immunol. 157:(7):1996;2939-2946.
55. Mollick J.A., Chintagumpala M., Cook R.G., Rich R.R. Staphylococcal exotoxin activation of T cells Role of exotoxin-MHC class II binding affinity and class II isotype . J Immunol. 146:(2):1991;463-468.